Inogen (INGN) Cash & Equivalents (2013 - 2026)

Inogen (INGN) has 14 years of Cash & Equivalents data on file, last reported at $93.1 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 21.68% year-over-year to $93.1 million in Q1 2026; TTM through Mar 2026 was $93.1 million, a 21.68% decrease from a year earlier, with the FY2025 full-year figure at $103.7 million, down 11.66% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $93.1 million, down from $103.7 million in the prior quarter.
• Over the last five years, Cash & Equivalents for INGN reached as high as $213.4 million in Q1 2022 and fell as low as $23.7 million in Q3 2023.
• Historically, Cash & Equivalents has averaged $105.9 million across 5 years, with a median of $105.7 million in 2024.
• Across the five-year window, Cash & Equivalents sank 88.82% in 2023 and jumped 350.23% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $187.0 million in 2022, then plunged by 32.9% to $125.5 million in 2023, then retreated by 6.44% to $117.4 million in 2024, then slipped by 11.66% to $103.7 million in 2025, then dropped by 10.24% to $93.1 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $93.1 million in Q1 2026, $103.7 million in Q4 2025, and $106.5 million in Q3 2025.